Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.
Zwaal
R F
RF
Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands.
Schroit
A J
AJ
D017209:Apoptosis; D001773:Blood Cells / Q000737:chemistry* / Q000502:physiology; D002118:Calcium / Q000097:blood; D002352:Carrier Proteins / Q000097:blood; D003167:Complement Activation; D004730:Endothelium, Vascular / Q000503:physiopathology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D008051:Lipid Bilayers / Q000737:chemistry; D008264:Macrophages / Q000502:physiology; D008563:Membrane Lipids / Q000097:blood*; D008565:Membrane Proteins / Q000097:blood; D008954:Models, Biological; D010714:Phosphatidylethanolamines / Q000097:blood; D010718:Phosphatidylserines / Q000097:blood; D049294:Phospholipid Transfer Proteins; D010743:Phospholipids / Q000097:blood*; D013499:Surface Properties; D013927:Thrombosis / Q000097:blood
D002352:Carrier Proteins; D008051:Lipid Bilayers; D008563:Membrane Lipids; D008565:Membrane Proteins; D010714:Phosphatidylethanolamines; D010718:Phosphatidylserines; D049294:Phospholipid Transfer Proteins; D010743:Phospholipids; D002118:Calcium